Premalignant gastric lesions in patients included in National colorectal cancer screening

Premalignant gastric lesions in patients included in National colorectal cancer screening

Gastric cancer is the fifth most common malignancy in the world with almost one million new cases annually. Helicobacter pylori infection causes 89% of all gastric cancers. Premalignant lesions (atrophy and intestinal metaplasia) develop after several decades of inflammation. Secondary prevention wi...

Full description

Bibliographic Details
Main Authors: Tepes Bojan, Seruga Maja, Vujasinovic Miroslav, Urlep Dejan, Ljepovic Liljana, Brglez Jurecic Nataša, Forte Alenka, Anita Kek Ljubec, Skvarc Miha
Format: Article
Language:English
Published: Sciendo 2017-12-01
Series:Radiology and Oncology
Subjects:
gastropanel
helicobacer pylori
atrophy
intestinal metaplasia
gastric cancer
Online Access:https://doi.org/10.1515/raon-2017-0054
Description
Summary:Gastric cancer is the fifth most common malignancy in the world with almost one million new cases annually. Helicobacter pylori infection causes 89% of all gastric cancers. Premalignant lesions (atrophy and intestinal metaplasia) develop after several decades of inflammation. Secondary prevention with gastroscopy is possible, but it is costly and has a low compliance rate. Alternative procedures like serology testing for pepsinogen I and II and pepsinogen I/II ratio are available to select patients for surveillance gastroscopies.
ISSN:1581-3207

Similar Items